Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 45

Cited In for PubMed (Select 16616896)

1.

Neurodevelopment, GABA system dysfunction, and schizophrenia.

Schmidt MJ, Mirnics K.

Neuropsychopharmacology. 2015 Jan;40(1):190-206. doi: 10.1038/npp.2014.95. Epub 2014 Apr 24.

PMID:
24759129
2.

Schizophrenia as a disorder of molecular pathways.

Horváth S, Mirnics K.

Biol Psychiatry. 2015 Jan 1;77(1):22-8. doi: 10.1016/j.biopsych.2014.01.001. Epub 2014 Jan 10.

PMID:
24507510
3.

Modulation of behavioral networks by selective interneuronal inactivation.

Schmidt MJ, Horvath S, Ebert P, Norris JL, Seeley EH, Brown J, Gellert L, Everheart M, Garbett KA, Grice TW, Caprioli RM, Mirnics K.

Mol Psychiatry. 2014 May;19(5):580-7. doi: 10.1038/mp.2013.167. Epub 2013 Dec 10.

4.

NEUROBIOLOGICAL ASPECTS OF SUICIDE AND SUICIDE ATTEMPTS IN BIPOLAR DISORDER.

Mathews DC, Richards EM, Niciu MJ, Ionescu DF, Rasimas JJ, Zarate CA Jr.

Transl Neurosci. 2013 Jun;4(2). doi: 10.2478/s13380-013-0120-7.

5.

The role of cannabinoid 1 receptor expressing interneurons in behavior.

Brown JA, Horváth S, Garbett KA, Schmidt MJ, Everheart M, Gellért L, Ebert P, Mirnics K.

Neurobiol Dis. 2014 Mar;63:210-21. doi: 10.1016/j.nbd.2013.11.001. Epub 2013 Nov 13.

6.

Patch-clamp recordings and calcium imaging followed by single-cell PCR reveal the developmental profile of 13 genes in iPSC-derived human neurons.

Belinsky GS, Rich MT, Sirois CL, Short SM, Pedrosa E, Lachman HM, Antic SD.

Stem Cell Res. 2014 Jan;12(1):101-18. doi: 10.1016/j.scr.2013.09.014. Epub 2013 Oct 3.

7.

Immune system disturbances in schizophrenia.

Horváth S, Mirnics K.

Biol Psychiatry. 2014 Feb 15;75(4):316-23. doi: 10.1016/j.biopsych.2013.06.010. Epub 2013 Jul 25. Review.

8.

Transcriptomic analysis of postmortem brain identifies dysregulated splicing events in novel candidate genes for schizophrenia.

Cohen OS, Mccoy SY, Middleton FA, Bialosuknia S, Zhang-James Y, Liu L, Tsuang MT, Faraone SV, Glatt SJ.

Schizophr Res. 2012 Dec;142(1-3):188-99. doi: 10.1016/j.schres.2012.09.015. Epub 2012 Oct 9.

9.

Disease- and age-related changes in histone acetylation at gene promoters in psychiatric disorders.

Tang B, Dean B, Thomas EA.

Transl Psychiatry. 2011 Dec 20;1:e64. doi: 10.1038/tp.2011.61.

10.

Transcriptome sequencing revealed significant alteration of cortical promoter usage and splicing in schizophrenia.

Wu JQ, Wang X, Beveridge NJ, Tooney PA, Scott RJ, Carr VJ, Cairns MJ.

PLoS One. 2012;7(4):e36351. doi: 10.1371/journal.pone.0036351. Epub 2012 Apr 27.

11.

Functional gene-expression analysis shows involvement of schizophrenia-relevant pathways in patients with 22q11 deletion syndrome.

van Beveren NJ, Krab LC, Swagemakers S, Buitendijk GH, Boot E, van der Spek P, Elgersma Y, van Amelsvoort TA.

PLoS One. 2012;7(3):e33473. doi: 10.1371/journal.pone.0033473. Epub 2012 Mar 22. Erratum in: PLoS One. 2012;7(4): doi/10.1371/annotation/d80f4e7d-5e96-41da-9dae-717b0d0d3c60. Buitendijk, Gabriella [corrected to Buitendijk, Gabriëlle H S]..

12.

Genome-wide expression profiling of schizophrenia using a large combined cohort.

Mistry M, Gillis J, Pavlidis P.

Mol Psychiatry. 2013 Feb;18(2):215-25. doi: 10.1038/mp.2011.172. Epub 2012 Jan 3.

13.

Expression profiling in neuropsychiatric disorders: emphasis on glutamate receptors in bipolar disorder.

Ginsberg SD, Hemby SE, Smiley JF.

Pharmacol Biochem Behav. 2012 Feb;100(4):705-11. doi: 10.1016/j.pbb.2011.09.015. Epub 2011 Oct 8. Review.

14.

Meta-analysis and genome-wide interpretation of genetic susceptibility to drug addiction.

Li CY, Zhou WZ, Zhang PW, Johnson C, Wei L, Uhl GR.

BMC Genomics. 2011 Oct 15;12:508. doi: 10.1186/1471-2164-12-508.

15.

Better understanding of mechanisms of schizophrenia and bipolar disorder: from human gene expression profiles to mouse models.

Lin CY, Sawa A, Jaaro-Peled H.

Neurobiol Dis. 2012 Jan;45(1):48-56. doi: 10.1016/j.nbd.2011.08.025. Epub 2011 Sep 3. Review.

16.

Genome-wide expression assay comparison across frozen and fixed postmortem brain tissue samples.

Chow ML, Li HR, Winn ME, April C, Barnes CC, Wynshaw-Boris A, Fan JB, Fu XD, Courchesne E, Schork NJ.

BMC Genomics. 2011 Sep 10;12:449. doi: 10.1186/1471-2164-12-449.

17.

Gene expression profiling of the brain: pondering facts and fiction.

Mitchell AC, Mirnics K.

Neurobiol Dis. 2012 Jan;45(1):3-7. doi: 10.1016/j.nbd.2011.06.001. Epub 2011 Jun 14. Review.

18.

Alternatively Spliced Genes as Biomarkers for Schizophrenia, Bipolar Disorder and Psychosis: A Blood-Based Spliceome-Profiling Exploratory Study.

Glatt SJ, Chandler SD, Bousman CA, Chana G, Lucero GR, Tatro E, May T, Lohr JB, Kremen WS, Everall IP, Tsuang MT.

Curr Pharmacogenomics Person Med. 2009 Sep;7(3):164-188.

19.

Ontogenetic de novo copy number variations (CNVs) as a source of genetic individuality: studies on two families with MZD twins for schizophrenia.

Maiti S, Kumar KH, Castellani CA, O'Reilly R, Singh SM.

PLoS One. 2011 Mar 2;6(3):e17125. doi: 10.1371/journal.pone.0017125.

20.

Synaptic changes in the brain of subjects with schizophrenia.

Faludi G, Mirnics K.

Int J Dev Neurosci. 2011 May;29(3):305-9. doi: 10.1016/j.ijdevneu.2011.02.013. Epub 2011 Mar 5. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk